1-20 of 38
Allan Lipton
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract P5-13-10: Elevated plasma IL-8 predicts for reduced outcomes in CCTG MA.38, a phase 2 randomized trial of palbociclib in ER+/HER2- metastatic breast cancer patients

Hyma V Polimera, Dhirisha Bhatt, Lois E Shepherd, Karen Gelmon, Anil A Joy, Wendy R Parulekar, Monika Joshi, Suhail M Ali, Kim Leitzel, Cristina Truica, Monali Vasekar, Joseph J Drabick, Harry Menon, Neal Shah, Ashok Maddukuri, Prashanth Moku, E. Scott Halstead, Daniel McKeone, Todd M Umstead, BE Chen, Allan Lipton
Journal: Cancer Research
Cancer Res (2022) 82 (4_Supplement): P5-13-10.
https://doi.org/10.1158/1538-7445.SABCS21-P5-13-10
Published: 15 February 2022
View articletitled, Abstract P5-13-10: Elevated plasma IL-8 predicts for reduced outcomes in CCTG MA.38, a phase 2 randomized trial of palbociclib in ER+/HER2- metastatic breast cancer patients
Journal Articles

Abstract P4-10-25: Pretreatment serum metabolome predicts PFS in first-line trastuzumab-treated metastatic breast cancer

Elizabeth O’Day, Kim Leitzel, Suhail M Ali, Bo Zhang, Chen Dong, Haiwei Gu, Xiajian Shi, Joseph J Drabick, Leah Cream, Monali Vasekar, Hyma V Polimera, Vinod Nagabhairu, Prashanth Moku, Ashok Maddukuri, Harry Menon, Neha Pancholy, Walter P Carney, Wolfgang Koestler, Allan Lipton
Journal: Cancer Research
Cancer Res (2020) 80 (4_Supplement): P4-10-25.
https://doi.org/10.1158/1538-7445.SABCS19-P4-10-25
Published: 15 February 2020
View articletitled, Abstract P4-10-25: Pretreatment serum metabolome predicts PFS in first-line trastuzumab-treated metastatic breast cancer
Journal Articles

Abstract 1041: PTHrP(12-48) localization is intracellular and it inhibits cell proliferation and osteoclastogenesis

Varinder Kaur, Archana Kamalakar, Nisreen Akel, Kim Leitzel, Allan Lipton, Larry J. Suva
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): 1041.
https://doi.org/10.1158/1538-7445.AM2015-1041
Published: 01 August 2015
View articletitled, Abstract 1041: PTHrP(12-48) localization is intracellular and it inhibits cell proliferation and osteoclastogenesis
Journal Articles

Abstract P4-06-07: Expression of growth hormone releasing hormone receptor ( GHRH-R ) in primary and metastatic mammary carcinomas

Mehrad Nadji, Norman L Block, Andrew V Shally, Jonathan Lara, Rick Michaelson, Suhail M Ali, Kim Leitzel, Syed M Rizvi, Mhd Yaser Al-Marrawi, Allan Lipton
Journal: Cancer Research
Cancer Res (2015) 75 (9_Supplement): P4-06-07.
https://doi.org/10.1158/1538-7445.SABCS14-P4-06-07
Published: 01 May 2015
View articletitled, Abstract P4-06-07: Expression of growth hormone releasing hormone receptor ( GHRH-R ) in primary and metastatic mammary carcinomas
Journal Articles

Abstract P3-06-14: Serum activin A and response to the aromatase inhibibitor (AI) letrozole versus tamoxifen in metastatic breast cancer

Meghan Jensen, Ashley Kang, Suhail M Ali, Kim Leitzel, Ashwani Garg, Jaqueline Rogerio, David Chen, Raymond Hall, Scott Hofsess, Hilary A Chaudri-Ross, Nicholas Bade, Walter P Carney, Allan Lipton
Journal: Cancer Research
Cancer Res (2015) 75 (9_Supplement): P3-06-14.
https://doi.org/10.1158/1538-7445.SABCS14-P3-06-14
Published: 01 May 2015
View articletitled, Abstract P3-06-14: Serum activin A and response to the aromatase inhibibitor (AI) letrozole versus tamoxifen in metastatic breast cancer
Journal Articles

Abstract 1538: Extracellular ferritin is a tumorigenic factor and is secreted by tumor-associated macrophages: A functional link between inflammation and tumorigenesis.

Ahmed A. Alkhateeb, Bing Han, Kim Leitzel, Suhail Ali, Allan Lipton, James Connor
Journal: Cancer Research
Cancer Res (2013) 73 (8_Supplement): 1538.
https://doi.org/10.1158/1538-7445.AM2013-1538
Published: 15 April 2013
View articletitled, Abstract 1538: Extracellular ferritin is a tumorigenic factor and is secreted by tumor-associated macrophages: A functional link between inflammation and tumorigenesis.
Journal Articles

Abstract 391: Serum ferritin predicts response to trastuzumab and is a biomarker for breast and pancreatic cancers: A potential novel inflammatory effector mechanism

Ahmed A. Alkhateeb, Lindsey Zubritsky, Kim Leitzel, Suhail M. Ali, Cynthia Campbell-Baird, Wolfgang Koestler, Eva-Marie Fuchs, Allan Lipton, James Connor
Journal: Cancer Research
Cancer Res (2012) 72 (8_Supplement): 391.
https://doi.org/10.1158/1538-7445.AM2012-391
Published: 15 April 2012
View articletitled, Abstract 391: Serum ferritin predicts response to trastuzumab and is a biomarker for breast and pancreatic cancers: A potential novel inflammatory effector mechanism
Journal Articles

Lactoferrin–Endothelin-1 Axis Contributes to the Development and Invasiveness of Triple-Negative Breast Cancer Phenotypes

Ngoc-Han Ha, Vasudha S. Nair, Divijendra Natha Sirigiri Reddy, Prakriti Mudvari, Kazufumi Ohshiro, Krishna Sumanth Ghanta, Suresh B. Pakala, Da-Qiang Li, Luis Costa, Allan Lipton, Rajendra A. Badwe, Suzanne Fuqua, Margaretha Wallon, George C. Prendergast, Rakesh Kumar
Journal: Cancer Research
Cancer Res (2011) 71 (23): 7259–7269.
https://doi.org/10.1158/0008-5472.CAN-11-1143
Published: 29 November 2011
View articletitled, Lactoferrin–Endothelin-1 Axis Contributes to the Development and Invasiveness of Triple-Negative Breast Cancer Phenotypes
Open the PDF for Lactoferrin–Endothelin-1 Axis Contributes to the Development and Invasiveness of Triple-Negative Breast Cancer Phenotypes in another window
Includes: Supplementary data
Journal Articles

Abstract 2276: Serum endoglin and uPA change predicts PFS and overall survival in first line trastuzumab-treated breast cancer

Matthew S. Evans, Hui Ying Hou, Uchechi Anyanwu, Kim Leitzel, Suhail M. Ali, Wolfgang Koestler, Eva-Maria Fuchs, Sheryl Brown-Shimer, Peter Hamer, Walter Carney, Allan Lipton
Journal: Cancer Research
Cancer Res (2011) 71 (8_Supplement): 2276.
https://doi.org/10.1158/1538-7445.AM2011-2276
Published: 15 April 2011
View articletitled, Abstract 2276: Serum endoglin and uPA change predicts PFS and overall survival in first line trastuzumab-treated breast cancer
Journal Articles

Trastuzumab Has Preferential Activity against Breast Cancers Driven by HER2 Homodimers

Ritwik Ghosh, Archana Narasanna, Shizhen Emily Wang, Shuying Liu, Anindita Chakrabarty, Justin M. Balko, Ana María González-Angulo, Gordon B. Mills, Elicia Penuel, John Winslow, Jeff Sperinde, Rajiv Dua, Sailaja Pidaparthi, Ali Mukherjee, Kim Leitzel, Wolfgang J. Kostler, Allan Lipton, Michael Bates, Carlos L. Arteaga
Journal: Cancer Research
Cancer Res (2011) 71 (5): 1871–1882.
https://doi.org/10.1158/0008-5472.CAN-10-1872
Published: 01 March 2011
View articletitled, Trastuzumab Has Preferential Activity against Breast Cancers Driven by HER2 Homodimers
Open the PDF for Trastuzumab Has Preferential Activity against Breast Cancers Driven by HER2 Homodimers in another window
Includes: Supplementary data
Journal Articles

Abstract 4651: Elevated serum tissue inhibitor of metalloproteinases-1 (TIMP-1) level predicts shorter survival in ovarian cancer

Navid Jamshidi, Vikas Shrivastava, Kim Leitzel, Suhail Ali, Edward Podczask, Colin Macneill, Timothy Deimling, Sheryl Brown-Shimer, Karen Pierce, Walter Carney, Syed Rizvi, Kamal Abbi, Allan Lipton
Journal: Cancer Research
Cancer Res (2010) 70 (8_Supplement): 4651.
https://doi.org/10.1158/1538-7445.AM10-4651
Published: 15 April 2010
View articletitled, Abstract 4651: Elevated serum tissue inhibitor of metalloproteinases-1 (TIMP-1) level predicts shorter survival in ovarian cancer
Journal Articles

Abstract #1620: Elevated serum MN (carbonic anhydrase IX) levels predict shorter survival in metastatic breast cancer

Shanthi Sivendran, Kim Leitzel, Suhail Ali, Dean Evans, Joel Miller, Peter Hamer, Sheryl Brown-Shimer, Walter Carney, Allan Lipton
Journal: Cancer Research
Cancer Res (2009) 69 (9_Supplement): 1620.
Published: 01 May 2009
View articletitled, Abstract #1620: Elevated serum MN (carbonic anhydrase IX) levels predict shorter survival in metastatic breast cancer
Journal Articles

Abstract #689: Elevated pretreatment serum TIMP-1 level predicts reduced PFS and overall survival in trastuzumab-treated metastatic breast cancer patients.

Uchechi Anyanwu, Hui Hou, Matthew Evans, Wolfgang Kostler, Eva-Maria Fuchs, Suhail Ali, Kim Leitzel, Laurence Demers, Peter Hamer, Karen Pierce, Sheryl Brown-Shimer, Walter Carney, Allan Lipton
Journal: Cancer Research
Cancer Res (2009) 69 (9_Supplement): 689.
Published: 01 May 2009
View articletitled, Abstract #689: Elevated pretreatment serum TIMP-1 level predicts reduced PFS and overall survival in trastuzumab-treated metastatic breast cancer patients.
Journal Articles

Abstract #2818: Growth inhibition of human breast cancer cells with an iron chelator and a dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor

Lois Witters, Uchechi Anyanwu, Hanspeter Nick, Wolfgang Hackl, Allan Lipton
Journal: Cancer Research
Cancer Res (2009) 69 (9_Supplement): 2818.
Published: 01 May 2009
View articletitled, Abstract #2818: Growth inhibition of human breast cancer cells with an iron chelator and a dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor
Journal Articles

Synergistic Inhibition with a Dual Epidermal Growth Factor Receptor/HER-2/neu Tyrosine Kinase Inhibitor and a Disintegrin and Metalloprotease Inhibitor

Lois Witters, Peggy Scherle, Steven Friedman, Jordan Fridman, Eian Caulder, Robert Newton, Allan Lipton
Journal: Cancer Research
Cancer Res (2008) 68 (17): 7083–7089.
https://doi.org/10.1158/0008-5472.CAN-08-0739
Published: 28 August 2008
View articletitled, Synergistic Inhibition with a Dual Epidermal Growth Factor Receptor/HER-2/neu Tyrosine Kinase Inhibitor and a Disintegrin and Metalloprotease Inhibitor
Open the PDF for Synergistic Inhibition with a Dual Epidermal Growth Factor Receptor/HER-2/neu Tyrosine Kinase Inhibitor and a Disintegrin and Metalloprotease Inhibitor in another window
Journal Articles

Elevated plasma TIMP-1 levels predict reduced survival in metastatic castration-resistant prostate cancer patients.

Roberto Vargas, Susanna Jacobus, Kim Leitzel, Meredith Regan, Peter Hamer, Karen Pierce, Sheryl Brown-Shimer, Walter Carney, Suhail Ali, Phillip Kantoff, Allan Lipton, William Oh
Journal: Cancer Research
Cancer Res (2008) 68 (9_Supplement): 996.
Published: 01 May 2008
View articletitled, Elevated plasma TIMP-1 levels predict reduced survival in metastatic castration-resistant prostate cancer patients.
Journal Articles

Inhibition of prostate cancer growth with the combination of celecoxib and an ADAM protease inhibitor

Mary Gelnett, Lois Witters, Peggy Scherle, Steven Friedman, Kim Leitzel, Allan Lipton
Journal: Cancer Research
Cancer Res (2008) 68 (9_Supplement): 1346.
Published: 01 May 2008
View articletitled, Inhibition of prostate cancer growth with the combination of celecoxib and an ADAM protease inhibitor
Journal Articles

Elevated serum MN (carbonic anhydrase IX) levels in metastatic breast cancer patient serum.

Shanthi Sivendran, Kim Leitzel, Suhail Ali, Dean Evans, Peter Hamer, Karen Pierce, Sheryl Brown-Shimer, Walter Carney, Allan Lipton
Journal: Cancer Research
Cancer Res (2007) 67 (9_Supplement): 2666.
Published: 01 May 2007
View articletitled, Elevated serum MN (carbonic anhydrase IX) levels in metastatic breast cancer patient serum.
Journal Articles

Synergistic growth inhibition of human cancer cells with atrasentan and a Bcl-2 inhibitor

Erik Nielson, Lois Witters, Kim Leitzel, Allan Lipton
Journal: Cancer Research
Cancer Res (2007) 67 (9_Supplement): 4893.
Published: 01 May 2007
View articletitled, Synergistic growth inhibition of human cancer cells with atrasentan and a Bcl-2 inhibitor
Journal Articles

Elevated DKK-1 levels in lytic prostate cancer cell line conditioned medium and   prostate cancer patient serum.

Kim Leitzel, Seth Ettenberg, Renee Walsh, David Stover, Vijay Modur, Edgar Braendle, Dean Evans, Laurence Demers, Suhail Ali, Luis Costa, Allan Lipton
Journal: Cancer Research
Cancer Res (2007) 67 (9_Supplement): 2665.
Published: 01 May 2007
View articletitled, Elevated DKK-1 levels in lytic prostate cancer cell line conditioned medium and   prostate cancer patient serum.